Standard Biotools | FLDM - Sales Revenues


Standard Biotools reported $21.1M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Agilent USD 1.84B 37M Mar/2026
Becton, Dickinson and Co. USD 5B 300M Jun/2026
Bio-Rad Laboratories USD 651M 58.9M Jun/2026
Bruker USD 838.5M 15.1M Jun/2026
Danaher USD 6.3B 350M Jun/2026
Illumina USD 1.16B 70M Jun/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
Nikon Corporation JPY 164.18B 29.08B Jun/2026
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Revvity USD 729.68M 18.68M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sony JPY 2.84T 200B Jun/2026
Standard Biotools USD 21.1M 2.7M Mar/2026
Thermo Fisher Scientific USD 11.99B 980M Jun/2026
Waters USD 1.64B 370M Jun/2026